List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 13.3. Anti-inflammatory and antipruritic medicines |
Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (D07AA Corticosteroids, weak (group I)). |
Bolivia | LINAME 2011 - 2013 | No observations |
Peru | 13.3 Anti-Inflammatories & Anti-Pruritics | No observations |
Colombia | 10.5 Corticosteroids | No observations |
List | Section | Observation |
---|---|---|
Bolivia | LINAME 2011 - 2013 | No observations |
List | Section | Observation |
---|---|---|
Colombia | 10.5 Corticosteroids | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 13.3. Anti-inflammatory and antipruritic medicines |
Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (D07AA Corticosteroids, weak (group I)). |
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 03. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS | No observations |
PAHO Strategic Fund Medicine List | 10. Antiallergics and medicines used in anaphylaxis | No observations |
Bolivia | LINAME 2011 - 2013 | No observations |
Peru | 03. Anti-Allergics and Medications for Anaphylaxis | No observations |
Peru | 18.1 Adrenal Hormones and Synthetic Substitutes | No observations |
Chile | Essential and Prioritized Medications | No observations |
Colombia | 3.1 Systemic Corticosteroids | No observations |
Training CSamouge 2022 | 3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS | No observations |
WHO Model List of Essential Medicines (2021) | 8.2.4 Hormones and antihormones |
Others observations: − Acute lymphoblastic leukaemia − Burkitt lymphoma |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
Cuba | 18.1 Hormonas adrenales y sustitutivos sintéticos | No observations |
List | Section | Observation |
---|---|---|
Cuba | 18.1 Hormonas adrenales y sustitutivos sintéticos | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 17.3. Anti-inflammatory medicines | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 17.3. Anti-inflammatory medicines | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 18.1. Adrenal hormones and synthetic substitutes | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 18.1. Adrenal hormones and synthetic substitutes | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 18.1. Adrenal hormones and synthetic substitutes | No observations |
Chile | Essential and Prioritized Medications | No observations |
Cuba | 18.1 Hormonas adrenales y sustitutivos sintéticos | No observations |